Roche Holding AG
Roche Holding AG (RHHBY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RHHBY · as of Jun 8, 2026
Key Statistics
Explore Roche Holding AG Data
rhhby stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 33.3%
The RHHBY analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $57.00, representing +10.72% upside from the current price of $51.48.
Competitors & Peers
rhhby competitorsRHHBY
AZNCF
CHGCF
CHGCY
DSKYF
DSNKYStock Performance
Full HistoryAbout Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. T…
what is roche holding ag · rhhby stock overview · roche holding ag company profile · who is roche holding ag ceo · rhhby OTC · roche holding ag headquarters · roche holding ag business segments
About Stock Overview & Key Data
Roche Holding AG (RHHBY) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Aug 20, 2003. As of the latest trading session, RHHBY stock price is $51.48, with a market capitalization of $331.6B. The stock has returned +26.02% over the past 12 months and -0.17% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Roche Holding AG stock is Hold, with an average 12-month price target of $57.00. In fiscal year 2025, Roche Holding AG reported revenue of $63.4B and net income of $12.9B. For detailed data — including Roche Holding AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Roche Holding AG (RHHBY) stock price is $51.48. The stock is traded on OTC under the ticker symbol RHHBY. The 52-week range is $37.51 – $60.85.